| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 8.12e-09 | 14 | 108 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.31e-07 | 23 | 108 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 4.52e-07 | 29 | 108 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.52e-07 | 29 | 108 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.04e-06 | 34 | 108 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.22e-06 | 145 | 108 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.40e-06 | 16 | 108 | 4 | GO:0042043 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.34e-06 | 18 | 108 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | glycolipid binding | 6.65e-06 | 49 | 108 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | cyclase activity | 7.91e-06 | 24 | 108 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 9.38e-06 | 25 | 108 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.87e-05 | 210 | 108 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 PSG11 FHOD3 HDGFL3 CEP350 PROM1 SETD2 PTPRC NFKB1 FES USH2A TOR1AIP1 KLHL17 | 2.35e-05 | 1099 | 108 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | calmodulin binding | 3.59e-05 | 230 | 108 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.86e-05 | 70 | 108 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.73e-05 | 73 | 108 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | phosphatase binding | 9.45e-05 | 264 | 108 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 1.18e-04 | 18 | 108 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.29e-04 | 90 | 108 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.50e-04 | 93 | 108 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 1.91e-04 | 21 | 108 | 3 | GO:0034987 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 4.07e-04 | 600 | 108 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 5.98e-04 | 7 | 108 | 2 | GO:0034988 | |
| GeneOntologyMolecularFunction | kinase binding | CDK9 ADCY4 ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 ADCY6 LATS1 PTPRC MYOM2 MAP2K3 MAP2K6 | 7.29e-04 | 969 | 108 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | bubble DNA binding | 7.94e-04 | 8 | 108 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | protein kinase binding | CDK9 ADCY4 ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 ADCY6 LATS1 PTPRC MAP2K3 MAP2K6 | 8.65e-04 | 873 | 108 | 13 | GO:0019901 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 9.19e-04 | 207 | 108 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 9.42e-04 | 208 | 108 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 1.02e-03 | 9 | 108 | 2 | GO:0003810 | |
| GeneOntologyMolecularFunction | actin binding | 1.17e-03 | 479 | 108 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.30e-03 | 149 | 108 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 1.59e-03 | 709 | 108 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK9 ERVK-6 MAP2K4 ABL1 ABL2 GNPTAB TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 1.65e-03 | 938 | 108 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.66e-03 | 316 | 108 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.97e-03 | 46 | 108 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 2.10e-03 | 47 | 108 | 3 | GO:0004712 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.50e-03 | 173 | 108 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | kinase activity | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 2.84e-03 | 764 | 108 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | chloride ion binding | 3.31e-03 | 16 | 108 | 2 | GO:0031404 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.74e-03 | 17 | 108 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.74e-03 | 17 | 108 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | antigen binding | 3.74e-03 | 190 | 108 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.27e-03 | 196 | 108 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.20e-03 | 293 | 108 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.50e-03 | 66 | 108 | 3 | GO:0005080 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 5.91e-03 | 398 | 108 | 7 | GO:0046982 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.05e-09 | 22 | 105 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.99e-09 | 14 | 105 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.51e-09 | 29 | 105 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 8.96e-09 | 15 | 105 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 8.96e-09 | 15 | 105 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 8.96e-09 | 15 | 105 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 8.96e-09 | 15 | 105 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.23e-08 | 32 | 105 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.30e-08 | 16 | 105 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.49e-08 | 33 | 105 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.80e-08 | 34 | 105 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.83e-08 | 17 | 105 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.83e-08 | 17 | 105 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.83e-08 | 17 | 105 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.06e-08 | 91 | 105 | 8 | GO:0051055 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.17e-08 | 35 | 105 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.52e-08 | 18 | 105 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 4.53e-08 | 20 | 105 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 5.92e-08 | 21 | 105 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 5.92e-08 | 21 | 105 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 5.92e-08 | 21 | 105 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CACNA1A ERVK-6 COL5A2 RELN SDK2 ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 PSG11 MYOM3 FHOD3 PROM1 TGM2 SETD2 NEO1 LATS1 FURIN HEY2 MYOM2 FOXH1 NOS1 PRKX | 7.66e-08 | 1483 | 105 | 25 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 9.72e-08 | 23 | 105 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.72e-08 | 23 | 105 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A RELN ABL1 ABL2 MAN2B1 PSG1 PSG2 PSG5 PSG6 NLGN4Y PSG11 NLGN1 ITPR3 STRN NLGN4X SCN9A NLGN2 OLFM2 NOS1 | 1.07e-07 | 891 | 105 | 19 | GO:0007610 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.22e-07 | 24 | 105 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.22e-07 | 24 | 105 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.22e-07 | 24 | 105 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.30e-07 | 10 | 105 | 4 | GO:0097105 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.37e-07 | 47 | 105 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.37e-07 | 47 | 105 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | MAP2K4 RELN ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 TYRO3 PTPRC ROS1 MAP2K3 MAP2K6 | 1.45e-07 | 405 | 105 | 13 | GO:0033674 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.52e-07 | 25 | 105 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.52e-07 | 25 | 105 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 2.04e-07 | 11 | 105 | 4 | GO:0006171 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.04e-07 | 11 | 105 | 4 | GO:0097104 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.19e-07 | 83 | 105 | 7 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.29e-07 | 27 | 105 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.54e-07 | 52 | 105 | 6 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.78e-07 | 28 | 105 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 3.16e-07 | 129 | 105 | 8 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | CACNA1A SUPT20HL1 PSG1 PSG2 PSG5 PSG6 PSG11 SUPT20HL2 ACSL4 SCAP MALRD1 NFKB1 NOS1 | 3.20e-07 | 434 | 105 | 13 | GO:0062012 |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 3.98e-07 | 239 | 105 | 10 | GO:0050777 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SDK2 ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 NLGN4Y HLA-DQB1 PSG11 CDHR3 TBX21 NLGN1 PTPRU TYRO3 NEO1 PTPRC NLGN4X LPP NLGN2 | 4.35e-07 | 1077 | 105 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 4.38e-07 | 13 | 105 | 4 | GO:0097090 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.75e-07 | 31 | 105 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | cellular response to sorbitol | 5.11e-07 | 4 | 105 | 3 | GO:0072709 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 5.45e-07 | 59 | 105 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.61e-07 | 32 | 105 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.61e-07 | 32 | 105 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 5.95e-07 | 96 | 105 | 7 | GO:0002704 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 6.04e-07 | 60 | 105 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.58e-07 | 33 | 105 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.68e-07 | 34 | 105 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 7.71e-07 | 145 | 105 | 8 | GO:0045833 | |
| GeneOntologyBiologicalProcess | endocytosis | ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 NLGN4Y PSG11 NLGN1 TYRO3 TGM2 PTPRC NLGN4X IGHG1 IGHG4 NLGN2 CLEC10A | 9.08e-07 | 827 | 105 | 17 | GO:0006897 |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 9.48e-07 | 149 | 105 | 8 | GO:0062014 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | MAP2K4 ADCY4 RELN ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 PSG11 ADCY2 ADCY7 TYRO3 TGM2 PTPRC ROS1 MAP2K3 MAP2K6 NOS1 | 9.50e-07 | 1028 | 105 | 19 | GO:0043085 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.10e-06 | 16 | 105 | 4 | GO:0007158 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | MAP2K4 RELN ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 TYRO3 PTPRC ROS1 MAP2K3 MAP2K6 | 1.25e-06 | 490 | 105 | 13 | GO:0051347 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.36e-06 | 38 | 105 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.52e-06 | 70 | 105 | 6 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.56e-06 | 39 | 105 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | MAP2K4 RELN ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 PTPRC MAP2K3 MAP2K6 | 1.73e-06 | 350 | 105 | 11 | GO:0045860 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.77e-06 | 40 | 105 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 NLGN4Y PSG11 NLGN1 TYRO3 TGM2 PTPRC NLGN4X IGHG1 IGHG4 NLGN2 CLEC10A NOS1 | 1.82e-06 | 1074 | 105 | 19 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.95e-06 | 73 | 105 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.01e-06 | 41 | 105 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.27e-06 | 42 | 105 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 2.40e-06 | 118 | 105 | 7 | GO:0001570 | |
| GeneOntologyBiologicalProcess | response to sorbitol | 2.54e-06 | 6 | 105 | 3 | GO:0072708 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | ABL1 ABL2 PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 INPP5D TBX21 TYRO3 PTPRC IGHG1 IGHG4 | 2.81e-06 | 614 | 105 | 14 | GO:0051249 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 2.91e-06 | 232 | 105 | 9 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.23e-06 | 45 | 105 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 3.34e-06 | 80 | 105 | 6 | GO:0046850 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.34e-06 | 124 | 105 | 7 | GO:0034109 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 3.61e-06 | 46 | 105 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 3.61e-06 | 46 | 105 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 3.83e-06 | 240 | 105 | 9 | GO:0002695 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 4.02e-06 | 47 | 105 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 4.05e-06 | 309 | 105 | 10 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 4.13e-06 | 128 | 105 | 7 | GO:0050795 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 4.69e-06 | 246 | 105 | 9 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 4.76e-06 | 85 | 105 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 4.76e-06 | 85 | 105 | 6 | GO:1903670 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 4.96e-06 | 49 | 105 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 4.96e-06 | 49 | 105 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 5.18e-06 | 187 | 105 | 8 | GO:0001909 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 5.21e-06 | 23 | 105 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 5.45e-06 | 87 | 105 | 6 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 5.49e-06 | 50 | 105 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 5.59e-06 | 134 | 105 | 7 | GO:0019217 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 5.60e-06 | 189 | 105 | 8 | GO:0010565 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 6.53e-06 | 193 | 105 | 8 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 6.78e-06 | 194 | 105 | 8 | GO:0043405 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 7.12e-06 | 139 | 105 | 7 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 7.34e-06 | 53 | 105 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 7.39e-06 | 25 | 105 | 4 | GO:0046058 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 7.80e-06 | 262 | 105 | 9 | GO:0048771 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 8.29e-06 | 264 | 105 | 9 | GO:0050866 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.34e-08 | 16 | 107 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A MAP2K4 ADCY4 RELN ABL1 ABL2 NLGN4Y TBX21 NLGN1 TMEM222 ADCY2 GPR179 KHSRP ITPR3 ACSL4 STRN NEO1 NLGN4X NLGN2 KLHL14 USH2A NOS1 KLHL17 | 4.88e-08 | 1228 | 107 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | CACNA1A MAP2K4 ADCY4 RELN ABL1 ABL2 NLGN4Y NLGN1 TMEM222 ADCY2 GPR179 KHSRP ITPR3 STRN NLGN4X NLGN2 NOS1 KLHL17 | 3.41e-07 | 858 | 107 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1A MAP2K4 ADCY4 RELN ABL1 ABL2 NLGN4Y NLGN1 TMEM222 ADCY2 GPR179 KHSRP ITPR3 STRN NLGN4X NLGN2 NOS1 KLHL17 | 3.52e-07 | 860 | 107 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 5.20e-07 | 4 | 107 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | apical plasma membrane | MGAM PSG1 PSG2 PSG5 PSG6 PSG11 SLC3A1 ITPR3 PROM1 SLC20A2 LHFPL5 USH2A | 7.46e-06 | 487 | 107 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | ciliary membrane | 1.12e-05 | 98 | 107 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG2 PSG5 PSG6 NLGN4Y PSG11 NLGN1 TYRO3 PROM1 NEO1 PTPRC NLGN4X IGHG1 IGHG4 FURIN ROS1 NLGN2 CLEC10A | 1.29e-05 | 1111 | 107 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | inhibitory synapse | 1.84e-05 | 31 | 107 | 4 | GO:0060077 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.59e-05 | 13 | 107 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | apical part of cell | MGAM PSG1 PSG2 PSG5 PSG6 PSG11 SLC3A1 ITPR3 PROM1 SLC20A2 LHFPL5 USH2A | 5.10e-05 | 592 | 107 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell projection membrane | 7.40e-05 | 431 | 107 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 9.95e-05 | 90 | 107 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.40e-04 | 20 | 107 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.51e-04 | 223 | 107 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.58e-04 | 157 | 107 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.37e-04 | 405 | 107 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.43e-04 | 170 | 107 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 2.44e-04 | 24 | 107 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.33e-04 | 519 | 107 | 10 | GO:0009897 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1A MAP2K4 RELN ABL1 TBX21 KHSRP ITPR3 ACSL4 STRN NEO1 KLHL14 USH2A KLHL17 | 3.40e-04 | 835 | 107 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | stereocilium | 4.34e-04 | 69 | 107 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | side of membrane | PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 NLGN1 ITPR3 PTPRC IGHG1 IGHG4 FES CLEC10A | 5.29e-04 | 875 | 107 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.92e-04 | 201 | 107 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | stereocilium bundle | 7.26e-04 | 79 | 107 | 4 | GO:0032421 | |
| GeneOntologyCellularComponent | adherens junction | 7.83e-04 | 212 | 107 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | receptor complex | 7.99e-04 | 581 | 107 | 10 | GO:0043235 | |
| GeneOntologyCellularComponent | cell body | CACNA1A MAP2K4 RELN ABL1 TBX21 KHSRP ITPR3 ACSL4 STRN NEO1 KLHL14 USH2A KLHL17 | 9.21e-04 | 929 | 107 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.12e-03 | 503 | 107 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.47e-03 | 523 | 107 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | T cell receptor complex | 1.52e-03 | 163 | 107 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.65e-03 | 166 | 107 | 5 | GO:0019814 | |
| GeneOntologyCellularComponent | postsynapse | CACNA1A ABL1 ABL2 NLGN4Y NLGN1 GPR179 STRN NEO1 NLGN4X NLGN2 OLFM2 NOS1 KLHL17 | 2.09e-03 | 1018 | 107 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | excitatory synapse | 2.24e-03 | 107 | 107 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.24e-03 | 451 | 107 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 2.27e-03 | 14 | 107 | 2 | GO:0071735 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 CDHR3 NEO1 SCN9A OLFM2 | 2.29e-03 | 785 | 107 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | 3.05e-03 | 583 | 107 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.15e-03 | 477 | 107 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 3.36e-03 | 17 | 107 | 2 | GO:0042571 | |
| GeneOntologyCellularComponent | anchoring junction | PSG1 PSG2 PSG5 PSG6 PSG11 CDHR3 PTPRU TGM2 STRN PTPRC LPP FES | 4.21e-03 | 976 | 107 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | cilium | PTCHD3 PSG1 PSG2 PSG5 PSG6 PSG11 ADCY6 PROM1 DNAI4 CEP126 USH2A | 6.28e-03 | 898 | 107 | 11 | GO:0005929 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 7.56e-08 | 17 | 95 | 5 | MP:0031047 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.54e-07 | 60 | 95 | 7 | MP:0009790 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.43e-07 | 21 | 95 | 5 | MP:0031415 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 4.81e-07 | 44 | 95 | 6 | MP:0031023 | |
| MousePheno | decreased fatty acid oxidation | 5.00e-07 | 24 | 95 | 5 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 9.35e-07 | 27 | 95 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.13e-06 | 28 | 95 | 5 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.93e-06 | 31 | 95 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.93e-06 | 31 | 95 | 5 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.60e-06 | 35 | 95 | 5 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 4.16e-06 | 36 | 95 | 5 | MP:0031412 | |
| MousePheno | abnormal carbon dioxide production | 6.00e-06 | 67 | 95 | 6 | MP:0008962 | |
| MousePheno | decreased muscle cell glucose uptake | 6.25e-06 | 39 | 95 | 5 | MP:0030022 | |
| MousePheno | abnormal vascular wound healing | 9.91e-06 | 73 | 95 | 6 | MP:0004883 | |
| MousePheno | decreased oxygen consumption | 1.57e-05 | 79 | 95 | 6 | MP:0005290 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.60e-05 | 47 | 95 | 5 | MP:0031617 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 1.71e-05 | 120 | 95 | 7 | MP:0009786 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.94e-05 | 82 | 95 | 6 | MP:0020914 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.96e-05 | 49 | 95 | 5 | MP:0020948 | |
| MousePheno | decreased susceptibility to viral infection | 2.22e-05 | 125 | 95 | 7 | MP:0002410 | |
| MousePheno | decreased memory B cell number | 2.48e-05 | 9 | 95 | 3 | MP:0008729 | |
| MousePheno | decreased cellular glucose uptake | 2.89e-05 | 53 | 95 | 5 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 3.17e-05 | 54 | 95 | 5 | MP:0010953 | |
| MousePheno | abnormal susceptibility to infection | ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 TBX21 TGM6 KHSRP PTPRC LRIG1 NFKB1 FES CLEC10A MAP2K3 | 4.44e-05 | 672 | 95 | 15 | MP:0001793 |
| MousePheno | abnormal memory B cell number | 4.82e-05 | 11 | 95 | 3 | MP:0008093 | |
| MousePheno | abnormal lipid oxidation | 5.74e-05 | 61 | 95 | 5 | MP:0010951 | |
| MousePheno | increased insulin secretion | 7.24e-05 | 64 | 95 | 5 | MP:0003058 | |
| MousePheno | abnormal response to infection | ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 TBX21 TGM6 KHSRP PTPRC LRIG1 NFKB1 FES CLEC10A MAP2K3 | 8.83e-05 | 714 | 95 | 15 | MP:0005025 |
| MousePheno | abnormal muscle cell glucose uptake | 9.03e-05 | 67 | 95 | 5 | MP:0004130 | |
| MousePheno | decreased respiratory quotient | 1.02e-04 | 110 | 95 | 6 | MP:0010379 | |
| MousePheno | abnormal memory B cell morphology | 1.05e-04 | 14 | 95 | 3 | MP:0002440 | |
| MousePheno | abnormal response to antigen | ABL1 PSG1 PSG2 PSG5 PSG6 PSG11 TBX21 TGM6 KHSRP PTPRC LRIG1 NFKB1 FES CLEC10A MAP2K3 | 1.06e-04 | 726 | 95 | 15 | MP:0020000 |
| MousePheno | disorganized myocardium | 1.52e-04 | 40 | 95 | 4 | MP:0002190 | |
| MousePheno | decreased energy expenditure | 1.57e-04 | 119 | 95 | 6 | MP:0004890 | |
| MousePheno | polyphagia | 2.10e-04 | 80 | 95 | 5 | MP:0001433 | |
| MousePheno | absent memory B cells | 2.72e-04 | 4 | 95 | 2 | MP:0008094 | |
| MousePheno | decreased B cell number | 3.38e-04 | 394 | 95 | 10 | MP:0005017 | |
| MousePheno | abnormal wound healing | 3.40e-04 | 193 | 95 | 7 | MP:0005023 | |
| MousePheno | abnormal oxygen consumption | 3.62e-04 | 195 | 95 | 7 | MP:0005288 | |
| MousePheno | abnormal professional antigen presenting cell morphology | MAN2B1 INPP5D GNPTAB TG TGM2 PTPRC IGHG1 SLC20A2 IGHG4 NFKB1 KLHL14 CLEC10A NOS1 GNS | 3.75e-04 | 726 | 95 | 14 | MP:0008195 |
| MousePheno | insulin resistance | 3.85e-04 | 197 | 95 | 7 | MP:0005331 | |
| MousePheno | abnormal glycogen homeostasis | 4.41e-04 | 144 | 95 | 6 | MP:0005438 | |
| MousePheno | abnormal lean body mass | DMXL2 PSG1 PSG2 PSG5 PSG6 PSG11 GNPTAB TGM6 SLC3A1 HDGFL3 TG ACSL4 NFKB1 LPP | 5.12e-04 | 749 | 95 | 14 | MP:0003959 |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 5.24e-04 | 55 | 95 | 4 | MP:0010834 | |
| MousePheno | abnormal colon morphology | 5.87e-04 | 152 | 95 | 6 | MP:0000495 | |
| MousePheno | abnormal susceptibility to viral infection | 6.17e-04 | 279 | 95 | 8 | MP:0020185 | |
| MousePheno | urinary bladder obstruction | 6.27e-04 | 25 | 95 | 3 | MP:0009552 | |
| MousePheno | abnormal cellular glucose uptake | 6.46e-04 | 102 | 95 | 5 | MP:0003925 | |
| MousePheno | abnormal renal water reabsorption | 6.73e-04 | 6 | 95 | 2 | MP:0010108 | |
| MousePheno | abnormal hippocampus CA2 region morphology | 6.73e-04 | 6 | 95 | 2 | MP:0008265 | |
| MousePheno | increased B-1 B cell number | 6.84e-04 | 59 | 95 | 4 | MP:0004977 | |
| MousePheno | abnormal B-1a B cell morphology | 7.30e-04 | 60 | 95 | 4 | MP:0008164 | |
| MousePheno | abnormal eye electrophysiology | 9.17e-04 | 228 | 95 | 7 | MP:0005551 | |
| MousePheno | increased mature B cell number | 9.91e-04 | 168 | 95 | 6 | MP:0008210 | |
| MousePheno | decreased mature B cell number | 1.01e-03 | 232 | 95 | 7 | MP:0008211 | |
| MousePheno | obese | 1.03e-03 | 113 | 95 | 5 | MP:0001261 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 1.08e-03 | 30 | 95 | 3 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 1.08e-03 | 30 | 95 | 3 | MP:0010840 | |
| MousePheno | failure of chorioallantoic fusion | 1.11e-03 | 67 | 95 | 4 | MP:0009657 | |
| MousePheno | increased incidence of induced tumors | 1.15e-03 | 173 | 95 | 6 | MP:0002021 | |
| MousePheno | abnormal macrophage morphology | 1.18e-03 | 463 | 95 | 10 | MP:0002446 | |
| MousePheno | abnormal left-right axis symmetry of the somites | 1.25e-03 | 8 | 95 | 2 | MP:0005224 | |
| MousePheno | abnormal mature B cell number | 1.27e-03 | 312 | 95 | 8 | MP:0013701 | |
| MousePheno | abnormal respiratory quotient | 1.33e-03 | 178 | 95 | 6 | MP:0004129 | |
| MousePheno | abnormal mature B cell morphology | 1.36e-03 | 244 | 95 | 7 | MP:0008171 | |
| MousePheno | abnormal induced morbidity/mortality | CACNA1A PSG1 PSG2 PSG5 PSG6 PSG11 KHSRP TGM2 IGHG1 IGHG4 NFKB1 MAP2K3 NOS1 | 1.40e-03 | 737 | 95 | 13 | MP:0001657 |
| Domain | Ig-like_fold | SDK2 PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 MYOM3 PTPRU TGM6 TYRO3 TGM2 NEO1 PTPRC LRIG1 IGHG1 IGHG4 NFKB1 ROS1 MYOM2 USH2A | 3.22e-10 | 706 | 105 | 21 | IPR013783 |
| Domain | - | SDK2 PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 MYOM3 PTPRU TGM6 TYRO3 TGM2 NEO1 PTPRC LRIG1 NFKB1 ROS1 MYOM2 USH2A | 4.64e-09 | 663 | 105 | 19 | 2.60.40.10 |
| Domain | Nlgn | 4.70e-09 | 5 | 105 | 4 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 6.33e-09 | 13 | 105 | 5 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 9.81e-09 | 14 | 105 | 5 | PS00941 | |
| Domain | COesterase | 9.81e-09 | 14 | 105 | 5 | PF00135 | |
| Domain | CarbesteraseB | 9.81e-09 | 14 | 105 | 5 | IPR002018 | |
| Domain | Adcy_conserved_dom | 1.40e-08 | 6 | 105 | 4 | IPR009398 | |
| Domain | DUF1053 | 1.40e-08 | 6 | 105 | 4 | PF06327 | |
| Domain | AC_N | 6.49e-08 | 8 | 105 | 4 | IPR032628 | |
| Domain | Adcy | 6.49e-08 | 8 | 105 | 4 | IPR030672 | |
| Domain | AC_N | 6.49e-08 | 8 | 105 | 4 | PF16214 | |
| Domain | IGc2 | 8.73e-08 | 235 | 105 | 11 | SM00408 | |
| Domain | Ig_sub2 | 8.73e-08 | 235 | 105 | 11 | IPR003598 | |
| Domain | IG_LIKE | SDK2 PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 MYOM3 PTPRU TYRO3 NEO1 LRIG1 IGHG1 IGHG4 MYOM2 | 1.02e-07 | 491 | 105 | 15 | PS50835 |
| Domain | Ig-like_dom | SDK2 PSG1 PSG2 PSG5 PSG6 HLA-DQB1 PSG11 MYOM3 PTPRU TYRO3 NEO1 LRIG1 IGHG1 IGHG4 MYOM2 | 1.39e-07 | 503 | 105 | 15 | IPR007110 |
| Domain | fn3 | 3.28e-07 | 162 | 105 | 9 | PF00041 | |
| Domain | FN3 | 1.00e-06 | 185 | 105 | 9 | SM00060 | |
| Domain | FN3 | 1.84e-06 | 199 | 105 | 9 | PS50853 | |
| Domain | A/G_cyclase_CS | 2.12e-06 | 17 | 105 | 4 | IPR018297 | |
| Domain | Nucleotide_cyclase | 2.72e-06 | 18 | 105 | 4 | IPR029787 | |
| Domain | - | 2.72e-06 | 18 | 105 | 4 | 3.30.70.1230 | |
| Domain | FN3_dom | 2.75e-06 | 209 | 105 | 9 | IPR003961 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.43e-06 | 19 | 105 | 4 | PS00452 | |
| Domain | Guanylate_cyc | 3.43e-06 | 19 | 105 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.43e-06 | 19 | 105 | 4 | PS50125 | |
| Domain | A/G_cyclase | 3.43e-06 | 19 | 105 | 4 | IPR001054 | |
| Domain | CYCc | 3.43e-06 | 19 | 105 | 4 | SM00044 | |
| Domain | Ig_2 | 3.43e-06 | 73 | 105 | 6 | PF13895 | |
| Domain | IG | SDK2 PSG1 PSG2 PSG5 PSG6 PSG11 MYOM3 PTPRU TYRO3 NEO1 LRIG1 MYOM2 | 4.33e-06 | 421 | 105 | 12 | SM00409 |
| Domain | Ig_sub | SDK2 PSG1 PSG2 PSG5 PSG6 PSG11 MYOM3 PTPRU TYRO3 NEO1 LRIG1 MYOM2 | 4.33e-06 | 421 | 105 | 12 | IPR003599 |
| Domain | ig | 1.19e-05 | 190 | 105 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.19e-05 | 190 | 105 | 8 | IPR013151 | |
| Domain | NLGN4 | 3.13e-05 | 2 | 105 | 2 | IPR030025 | |
| Domain | FABD | 3.13e-05 | 2 | 105 | 2 | SM00808 | |
| Domain | F_actin_bind | 3.13e-05 | 2 | 105 | 2 | PF08919 | |
| Domain | F-actin_binding | 3.13e-05 | 2 | 105 | 2 | IPR015015 | |
| Domain | PROTEIN_KINASE_ATP | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 5.47e-05 | 459 | 105 | 11 | PS00107 |
| Domain | Protein_kinase_ATP_BS | 5.48e-05 | 379 | 105 | 10 | IPR017441 | |
| Domain | Prot_kinase_dom | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 9.62e-05 | 489 | 105 | 11 | IPR000719 |
| Domain | Ig_I-set | 9.92e-05 | 190 | 105 | 7 | IPR013098 | |
| Domain | I-set | 9.92e-05 | 190 | 105 | 7 | PF07679 | |
| Domain | PROTEIN_KINASE_DOM | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 1.03e-04 | 493 | 105 | 11 | PS50011 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.29e-04 | 138 | 105 | 6 | IPR001245 | |
| Domain | TyrKc | 1.38e-04 | 88 | 105 | 5 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.38e-04 | 88 | 105 | 5 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 2.18e-04 | 97 | 105 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.18e-04 | 97 | 105 | 5 | IPR008266 | |
| Domain | Kinase-like_dom | CDK9 MAP2K4 ABL1 ABL2 TYRO3 LATS1 FES ROS1 MAP2K3 MAP2K6 PRKX | 2.36e-04 | 542 | 105 | 11 | IPR011009 |
| Domain | - | 5.61e-04 | 119 | 105 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 5.61e-04 | 119 | 105 | 5 | IPR029058 | |
| Domain | Pkinase_Tyr | 8.09e-04 | 129 | 105 | 5 | PF07714 | |
| Domain | Transglut_N | 1.10e-03 | 9 | 105 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 1.10e-03 | 9 | 105 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 1.10e-03 | 9 | 105 | 2 | IPR001102 | |
| Domain | Transglut_C | 1.10e-03 | 9 | 105 | 2 | PF00927 | |
| Domain | - | 1.10e-03 | 9 | 105 | 2 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 1.10e-03 | 9 | 105 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 1.10e-03 | 9 | 105 | 2 | IPR013808 | |
| Domain | Transglutaminase_C | 1.37e-03 | 10 | 105 | 2 | IPR008958 | |
| Domain | TGc | 1.67e-03 | 11 | 105 | 2 | SM00460 | |
| Domain | Transglut_core | 1.67e-03 | 11 | 105 | 2 | PF01841 | |
| Domain | Transglutaminase-like | 1.67e-03 | 11 | 105 | 2 | IPR002931 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | IPR000731 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | PS50156 | |
| Domain | SH2 | 2.54e-03 | 101 | 105 | 4 | PF00017 | |
| Domain | SH2 | 3.45e-03 | 110 | 105 | 4 | SM00252 | |
| Domain | C1-set | 3.48e-03 | 54 | 105 | 3 | PF07654 | |
| Domain | SH2 | 3.56e-03 | 111 | 105 | 4 | PS50001 | |
| Domain | SH2 | 3.68e-03 | 112 | 105 | 4 | IPR000980 | |
| Domain | - | 3.68e-03 | 112 | 105 | 4 | 3.30.505.10 | |
| Domain | V-set | 3.84e-03 | 184 | 105 | 5 | PF07686 | |
| Domain | IGc1 | 3.86e-03 | 56 | 105 | 3 | SM00407 | |
| Domain | Gal_mutarotase_SF_dom | 4.03e-03 | 17 | 105 | 2 | IPR011013 | |
| Domain | MAM | 4.03e-03 | 17 | 105 | 2 | SM00137 | |
| Domain | Ig_C1-set | 4.26e-03 | 58 | 105 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 4.26e-03 | 58 | 105 | 3 | IPR003006 | |
| Domain | MAM | 4.52e-03 | 18 | 105 | 2 | PF00629 | |
| Domain | MAM_dom | 4.52e-03 | 18 | 105 | 2 | IPR000998 | |
| Domain | MAM_2 | 4.52e-03 | 18 | 105 | 2 | PS50060 | |
| Domain | IG_MHC | 4.68e-03 | 60 | 105 | 3 | PS00290 | |
| Domain | Ig_V-set | 5.34e-03 | 199 | 105 | 5 | IPR013106 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | ADCY4 ADCY2 ADCY6 ADCY7 IGLV3-19 ITPR3 IGLV1-44 IGHG1 IGHG4 PRKX | 1.71e-10 | 95 | 82 | 10 | M29842 |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | ADCY4 ADCY2 ADCY6 ADCY7 IGLV3-19 ITPR3 IGLV1-44 IGHG1 IGHG4 FURIN PRKX | 2.98e-10 | 134 | 82 | 11 | M29840 |
| Pathway | REACTOME_LEISHMANIA_INFECTION | ADCY4 ABL1 ADCY2 ADCY6 ADCY7 IGLV3-19 ITPR3 IGLV1-44 IGHG1 IGHG4 FURIN NFKB1 PRKX | 3.73e-10 | 219 | 82 | 13 | M29836 |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 6.59e-09 | 101 | 82 | 9 | M1979 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.52e-08 | 20 | 82 | 5 | M759 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.23e-07 | 41 | 82 | 6 | M512 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.17e-07 | 10 | 82 | 4 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.17e-07 | 10 | 82 | 4 | MM14668 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 3.40e-07 | 11 | 82 | 4 | M27420 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 6.26e-07 | 29 | 82 | 5 | M47627 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.65e-07 | 54 | 82 | 6 | M26911 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-06 | 14 | 82 | 4 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.02e-06 | 14 | 82 | 4 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.38e-06 | 15 | 82 | 4 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.38e-06 | 15 | 82 | 4 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.38e-06 | 15 | 82 | 4 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 1.84e-06 | 16 | 82 | 4 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 1.84e-06 | 16 | 82 | 4 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.84e-06 | 16 | 82 | 4 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.84e-06 | 16 | 82 | 4 | M39849 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.22e-06 | 37 | 82 | 5 | M749 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 2.39e-06 | 17 | 82 | 4 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.39e-06 | 17 | 82 | 4 | M47544 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.02e-06 | 108 | 82 | 7 | M17034 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 3.75e-06 | 6 | 82 | 3 | M47636 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 4.09e-06 | 113 | 82 | 7 | M16817 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 4.76e-06 | 43 | 82 | 5 | M29837 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 5.90e-06 | 21 | 82 | 4 | M48342 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 9.76e-06 | 85 | 82 | 6 | M3578 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 1.03e-05 | 24 | 82 | 4 | MM1518 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 1.03e-05 | 24 | 82 | 4 | MM1515 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 1.03e-05 | 24 | 82 | 4 | M9670 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.03e-05 | 24 | 82 | 4 | M47520 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 1.23e-05 | 25 | 82 | 4 | M984 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.23e-05 | 52 | 82 | 5 | M5785 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.36e-05 | 90 | 82 | 6 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 1.36e-05 | 90 | 82 | 6 | M4013 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.44e-05 | 26 | 82 | 4 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.44e-05 | 26 | 82 | 4 | MM14495 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.63e-05 | 55 | 82 | 5 | M39763 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 1.63e-05 | 55 | 82 | 5 | M39685 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.66e-05 | 194 | 82 | 8 | M16312 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.69e-05 | 27 | 82 | 4 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.69e-05 | 27 | 82 | 4 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.96e-05 | 28 | 82 | 4 | M47647 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 2.26e-05 | 29 | 82 | 4 | M27431 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.26e-05 | 29 | 82 | 4 | M47515 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 2.48e-05 | 100 | 82 | 6 | MM15826 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.97e-05 | 31 | 82 | 4 | M47507 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.10e-05 | 154 | 82 | 7 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.37e-05 | 156 | 82 | 7 | M39475 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.38e-05 | 32 | 82 | 4 | MM15326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.38e-05 | 32 | 82 | 4 | M47506 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 3.70e-05 | 65 | 82 | 5 | M15 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.83e-05 | 33 | 82 | 4 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 3.83e-05 | 33 | 82 | 4 | M11575 | |
| Pathway | WP_THERMOGENESIS | 3.84e-05 | 108 | 82 | 6 | M39746 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | CDK9 MAP2K4 ADCY4 ABL1 ADCY2 ADCY6 ADCY7 IGLV3-19 ITPR3 IGLV1-44 IGHG1 IGHG4 FURIN NFKB1 NMT1 MAP2K3 MAP2K6 PRKX | 3.84e-05 | 1081 | 82 | 18 | M27548 |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | MGAM MAP2K4 ABL1 MAN2B1 PSG1 PSG2 PSG5 PSG6 PSG11 PTPRC IGHG1 IGHG4 NFKB1 MAP2K3 MAP2K6 NOS1 GNS | 4.77e-05 | 995 | 82 | 17 | MM14661 |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 4.85e-05 | 35 | 82 | 4 | M47969 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 5.47e-05 | 115 | 82 | 6 | M9387 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.49e-05 | 39 | 82 | 4 | MM14496 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 7.79e-05 | 178 | 82 | 7 | M2890 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 8.21e-05 | 15 | 82 | 3 | M47816 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.10e-04 | 43 | 82 | 4 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.10e-04 | 43 | 82 | 4 | M954 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.13e-04 | 82 | 82 | 5 | M27110 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.21e-04 | 44 | 82 | 4 | MM15709 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.22e-04 | 17 | 82 | 3 | MM1408 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.23e-04 | 133 | 82 | 6 | M16476 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.25e-04 | 258 | 82 | 8 | MM14572 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1A ADCY4 NLGN4Y NLGN1 ADCY2 ADCY6 ADCY7 NLGN4X NLGN2 PRKX | 1.31e-04 | 411 | 82 | 10 | M735 |
| Pathway | REACTOME_GPER1_SIGNALING | 1.32e-04 | 45 | 82 | 4 | M45008 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.38e-04 | 335 | 82 | 9 | MM14503 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.44e-04 | 46 | 82 | 4 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.44e-04 | 46 | 82 | 4 | MM1428 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.44e-04 | 46 | 82 | 4 | M39828 | |
| Pathway | PID_ANTHRAX_PATHWAY | 1.45e-04 | 18 | 82 | 3 | M267 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.45e-04 | 18 | 82 | 3 | M48098 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.70e-04 | 48 | 82 | 4 | M10775 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.76e-04 | 90 | 82 | 5 | M835 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.82e-04 | 143 | 82 | 6 | M27107 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 1.85e-04 | 49 | 82 | 4 | M39543 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.12e-04 | 147 | 82 | 6 | MM15854 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 2.33e-04 | 52 | 82 | 4 | M920 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.45e-04 | 151 | 82 | 6 | M39329 | |
| Pathway | WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES | 2.70e-04 | 22 | 82 | 3 | M39773 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.70e-04 | 22 | 82 | 3 | MM1443 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 2.75e-04 | 99 | 82 | 5 | MM15905 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 2.75e-04 | 99 | 82 | 5 | MM14624 | |
| Pathway | WP_IL1_SIGNALING | 2.89e-04 | 55 | 82 | 4 | M39346 | |
| Pathway | KEGG_MELANOGENESIS | 3.01e-04 | 101 | 82 | 5 | M7761 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.09e-04 | 23 | 82 | 3 | M2821 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.10e-04 | 56 | 82 | 4 | M27616 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 3.13e-04 | 158 | 82 | 6 | MM14812 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 3.45e-04 | 104 | 82 | 5 | M39625 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 3.79e-04 | 59 | 82 | 4 | MM15128 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 3.94e-04 | 165 | 82 | 6 | M39400 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 4.05e-04 | 60 | 82 | 4 | MM15708 | |
| Pubmed | 2.43e-12 | 14 | 109 | 6 | 1648219 | ||
| Pubmed | 6.86e-11 | 10 | 109 | 5 | 16615126 | ||
| Pubmed | 1.06e-10 | 24 | 109 | 6 | 34233187 | ||
| Pubmed | 1.25e-10 | 11 | 109 | 5 | 11299302 | ||
| Pubmed | 2.94e-10 | 28 | 109 | 6 | 8672132 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.48e-10 | 13 | 109 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.48e-10 | 13 | 109 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.48e-10 | 13 | 109 | 5 | 16638824 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 20044046 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 32150576 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 6265583 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.48e-10 | 13 | 109 | 5 | 12832451 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.48e-10 | 13 | 109 | 5 | 21670291 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 22162753 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 2702644 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 8380065 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 1279194 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 25724769 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.48e-10 | 13 | 109 | 5 | 22092845 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 11801635 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 3.48e-10 | 13 | 109 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 3.48e-10 | 13 | 109 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 3.48e-10 | 13 | 109 | 5 | 23800882 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 19285068 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 21760897 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.48e-10 | 13 | 109 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.48e-10 | 13 | 109 | 5 | 39168268 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 8402684 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 16619040 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.48e-10 | 13 | 109 | 5 | 8209741 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.48e-10 | 13 | 109 | 5 | 21949477 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 26219866 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 2133556 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 32521208 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 19406938 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.48e-10 | 13 | 109 | 5 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.48e-10 | 13 | 109 | 5 | 19358828 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 16680193 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.48e-10 | 13 | 109 | 5 | 34058224 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 10964771 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 32169849 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.48e-10 | 13 | 109 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.48e-10 | 13 | 109 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.48e-10 | 13 | 109 | 5 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.48e-10 | 13 | 109 | 5 | 23935487 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 15331748 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.48e-10 | 13 | 109 | 5 | 22406619 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.48e-10 | 13 | 109 | 5 | 25972571 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 19008452 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 3.48e-10 | 13 | 109 | 5 | 15220458 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 18843289 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 15207636 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 21081647 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 11133662 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 11483763 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 2164599 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 29396368 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 18003729 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 3.48e-10 | 13 | 109 | 5 | 33352461 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 38381498 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 20739537 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.48e-10 | 13 | 109 | 5 | 27695943 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 20404914 | ||
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 3.48e-10 | 13 | 109 | 5 | 32027621 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 3.48e-10 | 13 | 109 | 5 | 27777319 | |
| Pubmed | 3.48e-10 | 13 | 109 | 5 | 18848945 | ||
| Pubmed | 4.55e-10 | 5 | 109 | 4 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 4.55e-10 | 5 | 109 | 4 | 10996085 | |
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 5.39e-10 | 14 | 109 | 5 | 34666041 | |
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 5.39e-10 | 14 | 109 | 5 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 5.39e-10 | 14 | 109 | 5 | 32209360 | |
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 11994468 | ||
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 11850617 | ||
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 5.39e-10 | 14 | 109 | 5 | 26196244 | |
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 8896983 | ||
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 22962327 | ||
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 17623671 | ||
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 5.39e-10 | 14 | 109 | 5 | 18794798 | |
| Pubmed | 5.39e-10 | 14 | 109 | 5 | 23469261 | ||
| Interaction | NLGN3 interactions | 5.56e-08 | 99 | 107 | 8 | int:NLGN3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 3.39e-04 | 250 | 109 | 5 | chrXp22 | |
| Cytoband | 19q13.2 | 6.52e-04 | 164 | 109 | 4 | 19q13.2 | |
| Cytoband | 9q34.1 | 9.30e-04 | 19 | 109 | 2 | 9q34.1 | |
| Cytoband | 7q22.3 | 1.03e-03 | 20 | 109 | 2 | 7q22.3 | |
| Cytoband | Xp22.11 | 1.14e-03 | 21 | 109 | 2 | Xp22.11 | |
| Cytoband | 10p12.31 | 1.25e-03 | 22 | 109 | 2 | 10p12.31 | |
| Cytoband | 17q11.2 | 2.34e-03 | 110 | 109 | 3 | 17q11.2 | |
| Cytoband | 1q25.2 | 2.48e-03 | 31 | 109 | 2 | 1q25.2 | |
| Cytoband | 22q11.2 | 2.99e-03 | 120 | 109 | 3 | 22q11.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.56e-10 | 11 | 77 | 5 | 1315 | |
| GeneFamily | Fibronectin type III domain containing | 2.56e-08 | 160 | 77 | 9 | 555 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 6.26e-08 | 10 | 77 | 4 | 53 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 2.57e-06 | 7 | 77 | 3 | 653 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.39e-05 | 161 | 77 | 6 | 593 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 4.93e-04 | 8 | 77 | 2 | 658 | |
| GeneFamily | Transglutaminases | 6.32e-04 | 9 | 77 | 2 | 773 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 6.56e-04 | 163 | 77 | 5 | 590 | |
| GeneFamily | SH2 domain containing | 9.08e-04 | 101 | 77 | 4 | 741 | |
| GeneFamily | Immunoglobulin like domain containing | 1.40e-03 | 193 | 77 | 5 | 594 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.57e-03 | 21 | 77 | 2 | 813 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 6.49e-03 | 89 | 77 | 3 | 353 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.90e-07 | 32 | 107 | 5 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 3.04e-07 | 35 | 107 | 5 | MM757 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.54e-06 | 48 | 107 | 5 | MM531 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.55e-06 | 87 | 107 | 6 | MM851 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | PSG1 PSG2 PSG5 PSG6 PSG11 ADCY7 ACSL4 IGHG1 IGHG4 ROS1 NMT1 GNS | 1.94e-06 | 534 | 107 | 12 | MM1050 |
| Coexpression | KRAS.LUNG_UP.V1_DN | 1.96e-06 | 142 | 107 | 7 | M2893 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 2.30e-06 | 52 | 107 | 5 | M19766 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 2.57e-06 | 284 | 107 | 9 | M2885 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | MAN2B1 PSG1 PSG2 PSG5 PSG6 PSG11 LENG1 TNRC6B CEP350 STRN FURIN ANAPC4 | 3.65e-06 | 568 | 107 | 12 | MM3824 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL5A2 ABL2 MAN2B1 INPP5D ADCY6 ADCY7 GPR179 ITPR3 TYRO3 PTPRC LRIG1 PLXDC2 FES NLGN2 CLEC10A PRKX GNS | 1.12e-05 | 1242 | 107 | 17 | M1920 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.42e-05 | 75 | 107 | 5 | MM605 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.46e-05 | 128 | 107 | 6 | MM1000 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | 1.74e-05 | 198 | 107 | 7 | M5776 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | 1.86e-05 | 200 | 107 | 7 | M7022 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.92e-05 | 201 | 107 | 7 | MM1006 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL5A2 ABL2 MAN2B1 INPP5D ADCY6 ADCY7 GPR179 ITPR3 TYRO3 PTPRC LRIG1 PLXDC2 FES NLGN2 CLEC10A PRKX GNS | 2.36e-05 | 1316 | 107 | 17 | MM1052 |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 2.52e-05 | 141 | 107 | 6 | M2898 | |
| Coexpression | KRAS.AMP.LUNG_UP.V1_DN | 2.62e-05 | 142 | 107 | 6 | M2859 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 2.73e-05 | 143 | 107 | 6 | MM989 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.32e-05 | 219 | 107 | 7 | MM3826 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.03e-05 | 93 | 107 | 5 | M40279 | |
| Coexpression | HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP | 4.83e-05 | 49 | 107 | 4 | M41093 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 6.28e-05 | 166 | 107 | 6 | M1542 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 9.53e-05 | 179 | 107 | 6 | MM660 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.04e-04 | 182 | 107 | 6 | MM993 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN | 1.07e-04 | 60 | 107 | 4 | M4856 | |
| Coexpression | TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL | ABL2 MAN2B1 HLA-DQB1 PLXDC2 FURIN NFKB1 FES CLEC10A MAP2K3 GNS | 1.28e-04 | 577 | 107 | 10 | M41697 |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN | 1.30e-04 | 63 | 107 | 4 | MM591 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DMXL2 MAP2K4 ABL1 ZHX2 ACSL4 TGM2 PTPRC LRIG1 NMT1 NOS1 TOR1AIP1 | 1.47e-04 | 705 | 107 | 11 | M1410 |
| Coexpression | GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN | 1.48e-04 | 194 | 107 | 6 | M6908 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 1.52e-04 | 195 | 107 | 6 | M9892 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MAP2K4 RELN MAN2B1 ADAMTS4 GNPTAB TNRC6B FHOD3 SLC45A4 TYRO3 STRN NEO1 LRIG1 PLXDC2 NLGN2 | 1.58e-04 | 1102 | 107 | 14 | M2369 |
| Coexpression | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN | 1.65e-04 | 67 | 107 | 4 | M9325 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.69e-04 | 284 | 107 | 7 | MM987 | |
| Coexpression | GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN | 1.70e-04 | 199 | 107 | 6 | M8356 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN | 1.70e-04 | 199 | 107 | 6 | M8805 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN | 1.75e-04 | 200 | 107 | 6 | M8494 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.79e-04 | 201 | 107 | 6 | MM1294 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MAP2K4 RELN MAN2B1 ADAMTS4 GNPTAB TNRC6B FHOD3 SLC45A4 TYRO3 STRN NEO1 LRIG1 PLXDC2 NLGN2 | 1.94e-04 | 1124 | 107 | 14 | MM1070 |
| Coexpression | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN | 1.96e-04 | 70 | 107 | 4 | MM809 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | MAN2B1 HLA-DQB1 ITPR3 PROM1 MOXD1 PTPRC NLGN4X IGHG1 CLEC10A | 2.17e-04 | 501 | 107 | 9 | M5389 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 2.33e-04 | 506 | 107 | 9 | M39067 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 2.35e-04 | 135 | 107 | 5 | MM965 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 2.45e-04 | 302 | 107 | 7 | MM16604 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 2.51e-04 | 214 | 107 | 6 | M40005 | |
| Coexpression | KRAS.BREAST_UP.V1_DN | 3.07e-04 | 143 | 107 | 5 | M2887 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 3.21e-04 | 224 | 107 | 6 | M40145 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_DN | 3.27e-04 | 80 | 107 | 4 | M6455 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.68e-04 | 323 | 107 | 7 | M9150 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_DN | 4.12e-04 | 85 | 107 | 4 | MM590 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 4.14e-04 | 235 | 107 | 6 | MM978 | |
| Coexpression | GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP | 4.57e-04 | 156 | 107 | 5 | M6707 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 185 | 108 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.23e-08 | 191 | 108 | 8 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 4.17e-07 | 190 | 108 | 7 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.97e-07 | 195 | 108 | 7 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 5.14e-07 | 196 | 108 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.02e-06 | 153 | 108 | 6 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 2.91e-06 | 163 | 108 | 6 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.71e-06 | 170 | 108 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.83e-06 | 178 | 108 | 6 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 5.31e-06 | 181 | 108 | 6 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 5.31e-06 | 181 | 108 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-06 | 182 | 108 | 6 | 1d37c486173cc4629842893ddd5033987c04086f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-06 | 182 | 108 | 6 | aef67bdc6937b315522d39959e26c9b0acf7ab52 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-DC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.48e-06 | 182 | 108 | 6 | 087c9f88daf08f5d688b728c2386f91f210d2255 | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 5.66e-06 | 183 | 108 | 6 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 5.66e-06 | 183 | 108 | 6 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.02e-06 | 185 | 108 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 186 | 108 | 6 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.21e-06 | 186 | 108 | 6 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 186 | 108 | 6 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.21e-06 | 186 | 108 | 6 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.21e-06 | 186 | 108 | 6 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 186 | 108 | 6 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.40e-06 | 187 | 108 | 6 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 6.40e-06 | 187 | 108 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.40e-06 | 187 | 108 | 6 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 188 | 108 | 6 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.81e-06 | 189 | 108 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 189 | 108 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.01e-06 | 190 | 108 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.01e-06 | 190 | 108 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.23e-06 | 191 | 108 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 191 | 108 | 6 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-06 | 191 | 108 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 7.45e-06 | 192 | 108 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.45e-06 | 192 | 108 | 6 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.67e-06 | 193 | 108 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 7.67e-06 | 193 | 108 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.67e-06 | 193 | 108 | 6 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 7.90e-06 | 194 | 108 | 6 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.90e-06 | 194 | 108 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.14e-06 | 195 | 108 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-06 | 195 | 108 | 6 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-06 | 195 | 108 | 6 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.38e-06 | 196 | 108 | 6 | 07b557b8530c19ca5b31ad2eac00c36ef1939266 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 197 | 108 | 6 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 197 | 108 | 6 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 197 | 108 | 6 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.87e-06 | 198 | 108 | 6 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 8.87e-06 | 198 | 108 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.40e-06 | 200 | 108 | 6 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 9.40e-06 | 200 | 108 | 6 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.26e-05 | 139 | 108 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-05 | 144 | 108 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 148 | 108 | 5 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-05 | 158 | 108 | 5 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.30e-05 | 159 | 108 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 4.30e-05 | 159 | 108 | 5 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.84e-05 | 163 | 108 | 5 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-05 | 166 | 108 | 5 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 5.43e-05 | 167 | 108 | 5 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 167 | 108 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 168 | 108 | 5 | 8ee57814c7e9d45444f48b6b269c4d535bc4d5e1 | |
| ToppCell | facs-Heart-RV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 168 | 108 | 5 | c1a5f4f4d32a1f8583048db709a7037cc9357ad8 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 168 | 108 | 5 | a405f0de70293f68b4e000c1fc8a9ad33d56539a | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 5.59e-05 | 168 | 108 | 5 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 5.75e-05 | 169 | 108 | 5 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | URO-Lymphocyte-B-B_intermediate|URO / Disease, Lineage and Cell Type | 5.91e-05 | 170 | 108 | 5 | e11d1510518cedabeece96d4adbb90999e6326fa | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 170 | 108 | 5 | e4856e768d0088e42fbdb8e6039f5bc3daa0afdb | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.91e-05 | 170 | 108 | 5 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.91e-05 | 170 | 108 | 5 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-05 | 172 | 108 | 5 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-05 | 172 | 108 | 5 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 6.25e-05 | 172 | 108 | 5 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 172 | 108 | 5 | c260680f5455fce133b7b4158b4197fc76115779 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 173 | 108 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.42e-05 | 173 | 108 | 5 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-05 | 174 | 108 | 5 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.96e-05 | 176 | 108 | 5 | 91ad2c34144f72283ca112fd3b3784f2f6259f65 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 6.96e-05 | 176 | 108 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 177 | 108 | 5 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-05 | 178 | 108 | 5 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.35e-05 | 178 | 108 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-05 | 179 | 108 | 5 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| Computational | Neighborhood of EGFR | 7.14e-05 | 32 | 76 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.02e-04 | 35 | 76 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 2.11e-04 | 42 | 76 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 3.01e-04 | 46 | 76 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 3.84e-04 | 49 | 76 | 4 | GNF2_KISS1 | |
| Drug | NSC-4928 | 8.98e-09 | 58 | 105 | 7 | CID000221086 | |
| Drug | NIH-3 | 2.09e-08 | 19 | 105 | 5 | CID009822007 | |
| Drug | SK&F 82958 | 2.09e-08 | 19 | 105 | 5 | ctd:C071262 | |
| Drug | reproterol | 3.64e-08 | 21 | 105 | 5 | CID000025654 | |
| Drug | NAIN | 7.51e-08 | 24 | 105 | 5 | CID000195228 | |
| Drug | 2',5'-dd3'-FSBA | 8.78e-08 | 10 | 105 | 4 | CID003081206 | |
| Drug | NC-5Z | 8.78e-08 | 10 | 105 | 4 | CID003035914 | |
| Drug | AC1L40QM | 1.37e-07 | 11 | 105 | 4 | CID000099213 | |
| Drug | B-Mlvp | 1.37e-07 | 11 | 105 | 4 | CID000195648 | |
| Drug | AC1NY9KD | 1.37e-07 | 11 | 105 | 4 | CID005771741 | |
| Drug | AC1NE3N8 | 1.41e-07 | 178 | 105 | 9 | CID004636050 | |
| Drug | Nocloprostum | 1.71e-07 | 28 | 105 | 5 | CID006435380 | |
| Drug | FCE 23884 | 2.96e-07 | 13 | 105 | 4 | CID000065898 | |
| Drug | AC1L1DBR | 4.06e-07 | 33 | 105 | 5 | CID000002279 | |
| Drug | 6,7-ADTN | 4.06e-07 | 33 | 105 | 5 | CID000003153 | |
| Drug | phosphonate analog | 4.06e-07 | 33 | 105 | 5 | CID000475766 | |
| Drug | AAGTP | 5.03e-07 | 64 | 105 | 6 | CID000656407 | |
| Drug | BMY 42393 | 5.61e-07 | 15 | 105 | 4 | CID000131961 | |
| Drug | rhamnose | MGAM ADCY4 MAN2B1 PTCHD3 ADCY2 ADCY6 ADCY7 TG FURIN CLEC10A GNS | 7.86e-07 | 356 | 105 | 11 | CID000000840 |
| Drug | synthetic pyrethrins | 9.35e-07 | 71 | 105 | 6 | CID000002982 | |
| Drug | Mevinphos | 9.70e-07 | 17 | 105 | 4 | ctd:D008799 | |
| Drug | TpTpT | 1.02e-06 | 72 | 105 | 6 | CID006441083 | |
| Drug | AC1L1I54 | 1.24e-06 | 41 | 105 | 5 | CID000004426 | |
| Drug | Ts-I | 1.30e-06 | 75 | 105 | 6 | CID000445278 | |
| Drug | diphenyleneiodonium | 1.30e-06 | 232 | 105 | 9 | CID000003101 | |
| Drug | bromodeoxyuridine | MAP2K4 RELN PSG1 PSG2 PSG5 PSG6 PROM1 PTPRC MAP2K3 MAP2K6 NOS1 | 1.34e-06 | 376 | 105 | 11 | CID000006035 |
| Drug | hydrochlorothiazide | 1.41e-06 | 120 | 105 | 7 | CID000003639 | |
| Drug | Ro 41-9067 | 1.57e-06 | 19 | 105 | 4 | CID000125800 | |
| Drug | AC1L1IPV | 1.59e-06 | 43 | 105 | 5 | CID000004683 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA1A MAP2K4 ADCY4 ADCY6 ADCY7 ITPR3 LRIG1 MAP2K3 MAP2K6 NOS1 | 1.65e-06 | 308 | 105 | 10 | CID000001915 |
| Drug | OD-q | 1.82e-06 | 179 | 105 | 8 | CID000001456 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 1.85e-06 | 125 | 105 | 7 | CID000002603 | |
| Drug | AC1L3V8L | 1.89e-06 | 6 | 105 | 3 | CID000122778 | |
| Drug | benzeneacetamide | 2.24e-06 | 46 | 105 | 5 | CID000007680 | |
| Drug | Chebi:3796 | 2.41e-06 | 21 | 105 | 4 | CID006857420 | |
| Drug | NSC-692968 | 2.71e-06 | 85 | 105 | 6 | CID000392472 | |
| Drug | KT5720 | 2.73e-06 | 189 | 105 | 8 | CID000003844 | |
| Drug | GSK835726 | 2.93e-06 | 22 | 105 | 4 | CID005311268 | |
| Drug | lanthanum | 3.25e-06 | 136 | 105 | 7 | CID000023926 | |
| Drug | beta-CNA | 3.53e-06 | 23 | 105 | 4 | CID005486190 | |
| Drug | Scpb | 3.53e-06 | 23 | 105 | 4 | CID000123843 | |
| Drug | NS-398 | 3.77e-06 | 264 | 105 | 9 | CID000004553 | |
| Drug | 2-amino-4-phosphonobutyric acid | 4.04e-06 | 91 | 105 | 6 | CID000002207 | |
| Drug | TL-99 | 4.23e-06 | 24 | 105 | 4 | CID000122132 | |
| Drug | trimetoquinol | 4.23e-06 | 24 | 105 | 4 | CID000005581 | |
| Drug | AC1L8VEV | 4.23e-06 | 24 | 105 | 4 | CID000433433 | |
| Drug | Revivon | 5.01e-06 | 54 | 105 | 5 | CID000026644 | |
| Drug | PD 81,723 | 5.01e-06 | 25 | 105 | 4 | CID000122028 | |
| Drug | octimibate | 5.01e-06 | 25 | 105 | 4 | CID000065676 | |
| Drug | manganese-ATP | 5.01e-06 | 25 | 105 | 4 | CID000124341 | |
| Drug | HWY-289 | 5.25e-06 | 8 | 105 | 3 | CID000487138 | |
| Drug | AC1L1EV8 | 5.25e-06 | 8 | 105 | 3 | CID000002964 | |
| Drug | GI-3 | 5.44e-06 | 147 | 105 | 7 | CID011957433 | |
| Drug | metaproterenol | 5.90e-06 | 26 | 105 | 4 | CID000004086 | |
| Drug | lead compounds | 6.21e-06 | 150 | 105 | 7 | CID000073212 | |
| Drug | SM-10906 | 6.91e-06 | 27 | 105 | 4 | CID006442261 | |
| Drug | etorphine | 7.78e-06 | 59 | 105 | 5 | CID000026721 | |
| Drug | 14,15-dihydroforskolin | 7.85e-06 | 9 | 105 | 3 | CID000194193 | |
| Drug | prenalterol | 8.03e-06 | 28 | 105 | 4 | CID000042396 | |
| Drug | desacetylnantradol | 8.03e-06 | 28 | 105 | 4 | CID000125211 | |
| Drug | tetrahydrofurfuryl alcohol | 8.03e-06 | 28 | 105 | 4 | CID000007360 | |
| Drug | phytate | 9.10e-06 | 159 | 105 | 7 | CID000000890 | |
| Drug | nickel | CACNA1A MGAM ADCY4 NLGN1 ADCY2 ADCY6 ADCY7 ITPR3 SETD2 NFKB1 FES MAP2K3 | 9.22e-06 | 552 | 105 | 12 | CID000000934 |
| Drug | tolazoline | 9.28e-06 | 29 | 105 | 4 | CID000005504 | |
| Drug | calmidazolium chloride | 9.48e-06 | 160 | 105 | 7 | CID000002531 | |
| Drug | AC1L1F6H | 9.78e-06 | 106 | 105 | 6 | CID000003104 | |
| Drug | 2-(aminomethyl)pyrrolidine | 9.88e-06 | 161 | 105 | 7 | CID000072032 | |
| Drug | d 1b | 9.95e-06 | 62 | 105 | 5 | CID000449090 | |
| Drug | naphthalene-diisocyanate | 9.95e-06 | 62 | 105 | 5 | CID003033874 | |
| Drug | AC1N2DGT | 1.07e-05 | 30 | 105 | 4 | CID004045015 | |
| Drug | pP-8 | 1.12e-05 | 10 | 105 | 3 | CID000444681 | |
| Drug | delta-(l-alpha-aminoadipoyl)-l-cysteinyl-glycine | 1.12e-05 | 229 | 105 | 8 | CID004369448 | |
| Drug | 1-aminocyclopentane-1,3-dicarboxylate | 1.27e-05 | 111 | 105 | 6 | CID000001310 | |
| Drug | AC1L1TJF | 1.35e-05 | 66 | 105 | 5 | CID000003377 | |
| Drug | LD-CTA | 1.39e-05 | 32 | 105 | 4 | CID000065018 | |
| Drug | dopexamine | 1.39e-05 | 32 | 105 | 4 | CID000055483 | |
| Drug | AC1L1BDQ | 1.58e-05 | 173 | 105 | 7 | CID000001394 | |
| Drug | NO-cAMP | 1.68e-05 | 69 | 105 | 5 | CID006426615 | |
| Drug | AC1MPJID | 1.72e-05 | 117 | 105 | 6 | CID003386230 | |
| Drug | fenoldopam | 1.81e-05 | 70 | 105 | 5 | CID000003340 | |
| Drug | tyrphostin A1 | 2.00e-05 | 35 | 105 | 4 | CID000002063 | |
| Drug | zardaverine | 2.00e-05 | 35 | 105 | 4 | CID000005723 | |
| Drug | Tg 5 | 2.03e-05 | 12 | 105 | 3 | CID000205491 | |
| Drug | 3'-AMP | 2.07e-05 | 72 | 105 | 5 | CID000041211 | |
| Drug | NSC7524 | 2.19e-05 | 182 | 105 | 7 | CID000005657 | |
| Drug | AC1L1JGQ | 2.22e-05 | 73 | 105 | 5 | CID000005034 | |
| Drug | AC1L1DSZ | 2.25e-05 | 36 | 105 | 4 | CID000002494 | |
| Drug | chlorthalidone | 2.25e-05 | 36 | 105 | 4 | CID000002732 | |
| Drug | pyridinyl imidazole | 2.25e-05 | 36 | 105 | 4 | CID000005171 | |
| Drug | aluminum | 2.35e-05 | 184 | 105 | 7 | CID000104727 | |
| Drug | 1,3-dipropylxanthine | 2.37e-05 | 74 | 105 | 5 | CID000169317 | |
| Drug | AC1L1E5T | 2.37e-05 | 74 | 105 | 5 | CID000002653 | |
| Drug | UTP-NA | CDK9 MAP2K4 ADCY4 ADCY2 ADCY6 ADCY7 ITPR3 NFKB1 MAP2K3 MAP2K6 | 2.49e-05 | 420 | 105 | 10 | CID000001181 |
| Drug | practolol | 2.51e-05 | 37 | 105 | 4 | CID000004883 | |
| Drug | MAPTAM | 2.51e-05 | 37 | 105 | 4 | CID000123719 | |
| Drug | AC1L1CBF | 2.59e-05 | 336 | 105 | 9 | CID000001822 | |
| Drug | AC1L1BJN | 2.64e-05 | 13 | 105 | 3 | CID000001467 | |
| Drug | sclareol glycol | 2.64e-05 | 13 | 105 | 3 | CID000091915 | |
| Drug | nantradol hydrochloride | 2.64e-05 | 13 | 105 | 3 | CID000047652 | |
| Drug | 2g6p | 2.79e-05 | 38 | 105 | 4 | CID002740174 | |
| Disease | cD177 antigen measurement | 4.81e-07 | 18 | 107 | 4 | EFO_0021866 | |
| Disease | neuroticism measurement, cognitive function measurement | L3MBTL2 PTPRU ADCY2 TG STRN SCAP FURIN RBFOX1 NOS1 PUS7 ANAPC4 | 6.91e-06 | 566 | 107 | 11 | EFO_0007660, EFO_0008354 |
| Disease | Graves disease | 1.17e-05 | 81 | 107 | 5 | EFO_0004237 | |
| Disease | Melancholia | 1.49e-05 | 41 | 107 | 4 | C0025193 | |
| Disease | Depression, Neurotic | 1.49e-05 | 41 | 107 | 4 | C0282126 | |
| Disease | Depressive Syndrome | 1.65e-05 | 42 | 107 | 4 | C0086133 | |
| Disease | Endogenous depression | 2.37e-05 | 46 | 107 | 4 | C0011573 | |
| Disease | Unipolar Depression | 4.57e-05 | 259 | 107 | 7 | C0041696 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 6.82e-05 | 60 | 107 | 4 | MONDO_0005148, MONDO_0005277 | |
| Disease | Esophageal Achalasia | 7.78e-05 | 4 | 107 | 2 | C0014848 | |
| Disease | Idiopathic achalasia of esophagus | 7.78e-05 | 4 | 107 | 2 | C0859976 | |
| Disease | tropical spastic paraparesis (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:321 (is_implicated_in) | |
| Disease | eosinophil percentage of leukocytes | ADAMTS4 HLA-DQB1 INPP5D ADCY7 SLC45A4 TG SETD2 PTPRC NFKB1 LPP LHFPL5 | 8.60e-05 | 746 | 107 | 11 | EFO_0007991 |
| Disease | cervical cancer (is_implicated_in) | 1.75e-04 | 30 | 107 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | neutrophil percentage of granulocytes | 1.88e-04 | 228 | 107 | 6 | EFO_0007994 | |
| Disease | restrictive cardiomyopathy (is_implicated_in) | 1.94e-04 | 6 | 107 | 2 | DOID:397 (is_implicated_in) | |
| Disease | solute carrier family 22 member 16 measurement | 1.94e-04 | 6 | 107 | 2 | EFO_0802079 | |
| Disease | cortical thickness | COL5A2 RELN PSG1 TNRC6B HDGFL3 SLC45A4 TG STRN NEO1 MALRD1 PLXDC2 FURIN NFKB1 | 1.98e-04 | 1113 | 107 | 13 | EFO_0004840 |
| Disease | age of onset of asthma | 1.99e-04 | 79 | 107 | 4 | OBA_2001001 | |
| Disease | Asthma | 2.09e-04 | 80 | 107 | 4 | C0004096 | |
| Disease | Large cell carcinoma of lung | 2.13e-04 | 32 | 107 | 3 | C0345958 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.30e-04 | 447 | 107 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.37e-04 | 152 | 107 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.70e-04 | 7 | 107 | 2 | EFO_0801906 | |
| Disease | JT interval | 2.95e-04 | 248 | 107 | 6 | EFO_0007885 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0020829 | |
| Disease | cortical surface area measurement | CACNA1A COL5A2 RELN PSG1 TNRC6B SLC45A4 TG STRN NEO1 LRIG1 PLXDC2 NFKB1 FES HEY2 | 3.62e-04 | 1345 | 107 | 14 | EFO_0010736 |
| Disease | parental longevity | 4.47e-04 | 494 | 107 | 8 | EFO_0007796 | |
| Disease | Diabetes, Autoimmune | 5.51e-04 | 44 | 107 | 3 | C0205734 | |
| Disease | Brittle diabetes | 5.51e-04 | 44 | 107 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 5.51e-04 | 44 | 107 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 5.51e-04 | 44 | 107 | 3 | C3837958 | |
| Disease | susceptibility to influenza measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0803537 | |
| Disease | QRS complex, QRS duration | 5.89e-04 | 45 | 107 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 5.89e-04 | 45 | 107 | 3 | C0011854 | |
| Disease | hypothyroidism | 6.05e-04 | 284 | 107 | 6 | EFO_0004705 | |
| Disease | chronic kidney disease, Proteinuria | 7.01e-04 | 11 | 107 | 2 | EFO_0003884, HP_0000093 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 7.01e-04 | 11 | 107 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | diastolic blood pressure, systolic blood pressure | 7.56e-04 | 670 | 107 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | QRS duration | 7.77e-04 | 298 | 107 | 6 | EFO_0005055 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 8.40e-04 | 12 | 107 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | human papilloma virus infection, oropharynx cancer | 9.52e-04 | 53 | 107 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | Eczema | 9.52e-04 | 310 | 107 | 6 | HP_0000964 | |
| Disease | Genetic chronic primary adrenal insufficiency | 9.90e-04 | 13 | 107 | 2 | Orphanet_101960 | |
| Disease | asthma, Eczema, allergic rhinitis | 1.00e-03 | 121 | 107 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | colorectal cancer (is_implicated_in) | 1.00e-03 | 121 | 107 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | autoimmune thyroid disease | 1.17e-03 | 126 | 107 | 4 | EFO_0006812 | |
| Disease | Thyroid preparation use measurement | 1.19e-03 | 217 | 107 | 5 | EFO_0009933 | |
| Disease | white matter integrity | 1.31e-03 | 130 | 107 | 4 | EFO_0004641 | |
| Disease | visual perception measurement | 1.34e-03 | 223 | 107 | 5 | EFO_0009700 | |
| Disease | Sjogren syndrome | 1.37e-03 | 60 | 107 | 3 | EFO_0000699 | |
| Disease | childhood onset asthma | 1.39e-03 | 334 | 107 | 6 | MONDO_0005405 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.42e-03 | 133 | 107 | 4 | EFO_0010092 | |
| Disease | allergic rhinitis | 1.42e-03 | 133 | 107 | 4 | EFO_0005854 | |
| Disease | reticulocyte count | PSG1 INPP5D TNRC6B ZHX2 SLC45A4 STRN PTPRC ERAL1 NFKB1 LHFPL5 MAP2K3 | 1.46e-03 | 1045 | 107 | 11 | EFO_0007986 |
| Disease | allergic sensitization measurement | 1.50e-03 | 62 | 107 | 3 | EFO_0005298 | |
| Disease | response to acetylsalicylate | 1.51e-03 | 16 | 107 | 2 | GO_1903492 | |
| Disease | cathepsin L1 measurement | 1.51e-03 | 16 | 107 | 2 | EFO_0010619 | |
| Disease | pulse pressure measurement | PSG1 TNRC6B FHOD3 ZC2HC1C PROM1 MALRD1 LRIG1 PLXDC2 SLC20A2 FURIN LPP FES NMT1 | 1.59e-03 | 1392 | 107 | 13 | EFO_0005763 |
| Disease | eosinophil percentage of granulocytes | 1.66e-03 | 234 | 107 | 5 | EFO_0007996 | |
| Disease | asthma | 1.67e-03 | 751 | 107 | 9 | MONDO_0004979 | |
| Disease | neuroimaging measurement | COL5A2 RELN PSG1 HLA-DQB1 TNRC6B ZHX2 TG STRN NEO1 FURIN HEY2 | 1.74e-03 | 1069 | 107 | 11 | EFO_0004346 |
| Disease | basophil count, eosinophil count | 1.89e-03 | 241 | 107 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | tropical spastic paraparesis | 1.92e-03 | 18 | 107 | 2 | EFO_0007527 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.96e-03 | 68 | 107 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | body fat percentage | 2.04e-03 | 488 | 107 | 7 | EFO_0007800 | |
| Disease | body weight | MGAM RELN TNRC6B NLGN1 ADCY6 SETD2 MOXD1 LPP RBFOX1 HEY2 CLEC10A ANAPC4 | 2.07e-03 | 1261 | 107 | 12 | EFO_0004338 |
| Disease | angiopoietin-1 receptor measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0010600 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.15e-03 | 364 | 107 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | allergic disease, age at onset | 2.22e-03 | 71 | 107 | 3 | EFO_0004847, MONDO_0005271 | |
| Disease | adenosine diphosphate measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0010452 | |
| Disease | neoplasm of mature B-cells | 2.37e-03 | 20 | 107 | 2 | EFO_0000096 | |
| Disease | polymyositis | 2.37e-03 | 20 | 107 | 2 | EFO_0003063 | |
| Disease | allergic disease | 2.53e-03 | 258 | 107 | 5 | MONDO_0005271 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 2.62e-03 | 21 | 107 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | Autistic Disorder | 2.66e-03 | 261 | 107 | 5 | C0004352 | |
| Disease | Malignant tumor of colon | 2.72e-03 | 159 | 107 | 4 | C0007102 | |
| Disease | eosinophil count | ADAMTS4 PSG1 HLA-DQB1 INPP5D TBX21 ADCY7 ITPR3 TG SETD2 PTPRC NFKB1 LPP LHFPL5 | 2.85e-03 | 1488 | 107 | 13 | EFO_0004842 |
| Disease | Henoch-Schoenlein purpura | 2.87e-03 | 22 | 107 | 2 | EFO_1000965 | |
| Disease | susceptibility to scarlet fever measurement | 3.00e-03 | 79 | 107 | 3 | EFO_0008409 | |
| Disease | remission, hepatitis C virus infection | 3.14e-03 | 23 | 107 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | frailty measurement | 3.14e-03 | 23 | 107 | 2 | EFO_0009885 | |
| Disease | electrocardiography | 3.23e-03 | 530 | 107 | 7 | EFO_0004327 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 3.41e-03 | 24 | 107 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.57e-03 | 84 | 107 | 3 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKAAYNPGQAVPWNA | 96 | Q8N163 | |
| KCQPYWEGPNNGITQ | 286 | O00555 | |
| DWQEGGYTINDKPNP | 501 | O60488 | |
| LVSPPNTEGNQWYDF | 486 | Q9UJX5 | |
| KNGQGWVPSNYITPV | 151 | P42684 | |
| KPQYDIWGNTVNVSS | 1101 | O43306 | |
| VIGAQKPQYDIWGNT | 996 | Q8NFM4 | |
| KPQYDIWGNTVNVAS | 1001 | Q8NFM4 | |
| SIWQVNQTASNPKPY | 2831 | Q8TDJ6 | |
| KPQYDIWGNTVNVAS | 1006 | P51828 | |
| FSWPGTQKQQEAPVE | 91 | Q3ZCQ2 | |
| EPNPGFWSQLQKYEE | 141 | Q4G0W2 | |
| PYPKWNSVFDQLTQV | 306 | P45985 | |
| NPEEGWQLYTSAQAP | 26 | O95897 | |
| FPRVTPTANQWDYKN | 1576 | Q14573 | |
| QVPCSPWKQYGQEEE | 251 | Q8NG50 | |
| QQTSSGTNNKPYRPW | 316 | Q9UBP5 | |
| FQGVPPNKSIYDVWV | 331 | O75593 | |
| PNPQIAWQKDGGTDF | 626 | Q96JA1 | |
| SYQFWDTQPVPKLGE | 116 | P30419 | |
| GQKVYLTWPVPNCAE | 426 | Q3T906 | |
| SPKWPQADGYVGDTQ | 211 | Q6PRD1 | |
| PSWEPNSQTKRYSGN | 266 | O95835 | |
| ELTPPKGYEAQTFNW | 496 | Q969R5 | |
| YLGQSAAEAQTQPPW | 116 | Q96BZ8 | |
| VWPGQTVFPDYTNPN | 491 | O43451 | |
| QPYWIGDSVNTPQAG | 46 | Q8TAF8 | |
| YNVQQKTAVWEEGPG | 366 | O75616 | |
| NTVNWYQQLPGTAPK | 51 | P01699 | |
| TYGQQGHPNTWKREP | 316 | Q93052 | |
| TYWTNFAKTGDPNQP | 581 | Q8N2Q7 | |
| WEIENNPGVKFTGYQ | 86 | Q9Y3E1 | |
| FYPAGSQPVTWAIDN | 2111 | P78509 | |
| WGKGNVPVVLNNPYS | 266 | P29475 | |
| KWEEPQEPNGLITQY | 506 | Q92729 | |
| TAPQDQKASIQIYPW | 111 | P09630 | |
| ADWYQQKPGQAPELV | 51 | A0A075B6J6 | |
| VNPVYGNWSNPEKTE | 2116 | Q5VYJ5 | |
| YWTNFAKTGDPNQPV | 526 | Q8NFZ3 | |
| GPPDAEYWNSQKEVL | 86 | P01920 | |
| IGAQKPQYDIWGNTV | 1011 | Q08462 | |
| WVPRYTGVAPQDQCK | 606 | O75173 | |
| CYDPKGDQWNILQTP | 541 | Q9P2G3 | |
| EKYEPQVNVWSPVAS | 501 | Q6TDP4 | |
| PYQEDTDQWNLGPQT | 246 | A2AJT9 | |
| NPTEVYVNDSVWVPG | 121 | Q69384 | |
| LQYPNVFWINPKTGE | 506 | Q6ZTQ4 | |
| VLPSWEYFNSKEQNP | 336 | Q9P2H0 | |
| QEPTDPKFPQQWYLS | 111 | P09958 | |
| APVQPKTESDYIWDQ | 776 | Q2V2M9 | |
| YDVQQAPQEDGPWTK | 861 | Q5VT06 | |
| EAQTKNGQGWVPSNY | 101 | P00519 | |
| KQSGEYWIDPNQGSV | 1306 | P05997 | |
| SPWTAAPQYQKAFQN | 236 | P15586 | |
| PTWKLNQTEPVAGNY | 761 | O00754 | |
| IWQQENVKPSLSFYP | 731 | Q5VTH9 | |
| YPSDIAVEWESNGQP | 256 | P01857 | |
| WESNGQPENNYKTTP | 261 | P01861 | |
| GSITPEVWPNVDNYE | 246 | P50750 | |
| NPPAQYSWTINGKFQ | 266 | Q9UQ72 | |
| QSVPAQKANPFYEEW | 1916 | Q58EX2 | |
| SDRKQGEPTEQPEWY | 71 | Q12770 | |
| YKQGGVTQEAATPVW | 521 | Q08357 | |
| TYWTNFAKTGDPNQP | 536 | Q8NFZ4 | |
| YWTNFAKTGDPNQPV | 526 | Q8N0W4 | |
| PAQYSWTINEKFQLP | 361 | P11464 | |
| PDSATGPQWYQESQE | 21 | Q3KNS1 | |
| FPYESWGTPFQQLKQ | 266 | P46734 | |
| PYDSWGTPFQQLKQV | 256 | P52564 | |
| QVPVKWTAPEALNYG | 721 | P07332 | |
| PGAPPQQDYTKAWEE | 636 | Q92945 | |
| SFNVSWTEPEYPNGV | 2256 | O75445 | |
| TVNPYTNGWKLNPVV | 201 | Q9NWB1 | |
| QGWNTTNPNIDPYDS | 541 | O43815 | |
| RYSWPSVKPQQEQSD | 241 | Q3ZLR7 | |
| ASWYQQKPGQAPVLV | 51 | P01714 | |
| DSNPPAEYSWTINGK | 356 | Q00889 | |
| NWQPPSEANGKITGY | 976 | Q92859 | |
| GQPSSTDAPKAWNYE | 21 | O43490 | |
| KPGDQILDWQYGVTQ | 31 | Q6UX71 | |
| PQNVSWEVVAYDDPK | 581 | Q96PZ0 | |
| NNPPDWTKNVEYTFT | 146 | Q15858 | |
| DQQPTAWSYDQPPKD | 936 | Q92835 | |
| NGKTIPPNNWLSVYG | 246 | Q07837 | |
| RYSWPSVKPQQEQSD | 241 | P0C7V6 | |
| YATGFQNWKPGQPDD | 256 | Q8IUN9 | |
| DPKAPSNSTAWQAYN | 541 | Q5BKX6 | |
| YEGWQALDPTPQEKS | 351 | P21980 | |
| SGYQKTPQEWAPQTA | 281 | Q5JTV8 | |
| NQDVPIPNKDTTYWC | 191 | Q6UVY6 | |
| ATGVPVDPSTVWYQN | 151 | Q8IY51 | |
| QNWTYEVKVSTQDPP | 606 | P08922 | |
| YPENDWDTAAPVPQK | 336 | P51817 | |
| APGPVQGQNYSVWDS | 2261 | Q9BYW2 | |
| SGPQSWYPKANNQDF | 111 | Q53FD0 | |
| WKLDPAQVYASGPNA | 106 | Q9H0R3 | |
| QWPTPQEYDQLAAKT | 651 | Q9Y6X8 | |
| NPPAQYSWTINGKFQ | 266 | P11465 | |
| WQTEEYQPPVAVDGK | 736 | Q01831 | |
| NPPAEYFWTINGKFQ | 266 | Q15238 | |
| QYTNWSVEQLPAEPK | 1121 | P08575 | |
| GWYQKPIAQNNAPSF | 2061 | P01266 | |
| GPSYNGWQVLDATPQ | 346 | O95932 | |
| QAKDVVPQAYWLGAP | 376 | Q9UL17 | |
| GPYKLSWVQDNGTQD | 356 | Q06418 | |
| WKGIQNIDPESDPYV | 1486 | Q9UPQ9 | |
| TVQGFPTPVVQWYKD | 176 | P54296 | |
| TVQASPPPQVTWYKN | 176 | Q5VTT5 | |
| WEDVPGDQVKPDQYT | 151 | Q5VU43 | |
| SWQVFDILNGKPYEP | 781 | P19838 |